Chayce David Clark is EVP and General Counsel of NU SKIN ENTERPRISES, INC.. Currently has a direct ownership of 233,140 shares of NUS, which is worth approximately $2.7 Million. The most recent transaction as insider was on Sep 03, 2025, when has been sold 20,000 shares (Class A Common Stock) at a price of $11.97 per share, resulting in proceeds of $239,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 233K
7.98% 3M change
48.5% 12M change
Total Value Held $2.7 Million

Chayce David Clark Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2025
SELL
Open market or private sale
$239,400 $11.97 p/Share
20,000 Reduced 7.9%
233,140 Class A Common Stock
Aug 01 2025
SELL
Payment of exercise price or tax liability
$1,680 $8.2 p/Share
205 Reduced 0.08%
253,140 Class A Common Stock
Feb 26 2025
BUY
Grant, award, or other acquisition
-
113,196 Added 30.88%
253,345 Class A Common Stock
Feb 15 2025
SELL
Payment of exercise price or tax liability
$107,556 $7.56 p/Share
14,227 Reduced 9.22%
140,149 Class A Common Stock
Feb 12 2025
BUY
Grant, award, or other acquisition
-
6,451 Added 4.01%
154,376 Class A Common Stock
Dec 20 2024
SELL
Payment of exercise price or tax liability
$59,862 $6.6 p/Share
9,070 Reduced 5.78%
147,925 Class A Common Stock
Aug 01 2024
SELL
Payment of exercise price or tax liability
$2,255 $10.95 p/Share
206 Reduced 0.13%
156,995 Class A Common Stock
Jun 05 2024
SELL
Payment of exercise price or tax liability
$13,119 $13.47 p/Share
974 Reduced 0.62%
157,201 Class A Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
69,116 Added 30.41%
158,175 Class A Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$77,198 $13.82 p/Share
5,586 Reduced 5.9%
89,059 Class A Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
3,522 Added 3.59%
94,645 Class A Common Stock
Dec 20 2023
SELL
Payment of exercise price or tax liability
$174,960 $19.29 p/Share
9,070 Reduced 9.05%
91,123 Class A Common Stock
Aug 01 2023
SELL
Payment of exercise price or tax liability
$6,126 $29.74 p/Share
206 Reduced 0.21%
100,193 Class A Common Stock
Jun 05 2023
SELL
Payment of exercise price or tax liability
$33,031 $33.74 p/Share
979 Reduced 0.97%
100,399 Class A Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
18,090 Added 15.14%
101,378 Class A Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$59,130 $45.38 p/Share
1,303 Reduced 1.54%
83,288 Class A Common Stock
Dec 20 2022
BUY
Grant, award, or other acquisition
-
61,836 Added 42.23%
84,591 Class A Common Stock
Aug 01 2022
SELL
Payment of exercise price or tax liability
$6,105 $44.56 p/Share
137 Reduced 0.6%
22,755 Class A Common Stock
Jun 05 2022
SELL
Payment of exercise price or tax liability
$30,445 $46.91 p/Share
649 Reduced 2.76%
22,892 Class A Common Stock
Feb 25 2022
BUY
Grant, award, or other acquisition
-
8,430 Added 26.37%
23,541 Class A Common Stock
Feb 15 2022
SELL
Payment of exercise price or tax liability
$42,947 $49.65 p/Share
865 Reduced 5.41%
15,111 Class A Common Stock
Aug 01 2021
BUY
Grant, award, or other acquisition
-
1,863 Added 10.44%
15,976 Class A Common Stock
CDC

Chayce David Clark

EVP and General Counsel
Provo, UT

Track Institutional and Insider Activities on NUS

Follow NU SKIN ENTERPRISES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUS shares.

Notify only if

Insider Trading

Get notified when an Nu Skin Enterprises, Inc. insider buys or sells NUS shares.

Notify only if

News

Receive news related to NU SKIN ENTERPRISES, INC.

Track Activities on NUS